Orangekloud Technology Inc. - Class A Ordinary Shares (ORKT)

On our desk, ORKT is viewed strictly as a speculative micro-cap shell play rather than a fundamental technology investment. With a market cap hovering between $5.9M and $7.5M and a share price sitting right around $1.01, liquidity is thin and highly volatile. Retail sentiment tracking shows high sensitivity to the ongoing Nasdaq delisting appeals. Anyone stepping into this name needs to treat it like an event-driven binary option tied strictly to corporate survival catalysts rather than a traditional SaaS holding.

From a risk management standpoint, the Form 20-F details are alarming. Even though revenue ticked up to S$5.7 million for fiscal year 2025 from S$4.0 million previously, the company explicitly warns of historical losses and an inability to guarantee sustained profitability. More importantly, Simply Wall St filings point out that they have less than a year of cash runway. Without a successful execution of the Orbis-VeVe merger, capital depletion remains an immediate threat to equity holders.

Looking at institutional tracking for Q2 2026, big money is essentially treating ORKT as radioactive. Regulatory filings show only 8 hedge funds and institutions holding a paltry $87.3K in aggregate value. Major players like HRT Financial and Renaissance Technologies completely exited their positions, while micro-allocations from firms like UBS Financial Services remain negligible. This absence of institutional sponsorship underscores why retail social sentiment on StockTwits and Twitter drives the entirety of the intraday price action.

When evaluating the operational pivot, our research indicates the proposed reverse merger with Orbis Technology Limited is a tactical survival play. Orbis brings VeVe, a global digital intellectual property infrastructure and marketplace for licensed digital assets. While the narrative of pivoting toward digital collectibles and NFTs sounds exciting on paper, the operational integration hurdles and potential shareholder dilution are massive red flags that analysts must stress-test during due diligence.

The regulatory timeline is the absolute core of our thesis right now. Following the January 29, 2026 Staff Delisting Determination from Nasdaq because the stock dipped below the $1.00 threshold, the company has been fighting an uphill battle. The February merger deadline and the pending appeal determinations are the binary catalysts that will either grant this Singapore-based SaaS micro-cap a new lease on life via the VeVe ecosystem or force an unceremonious exit from the exchange.